EP1802961A2 - Host-guest enery-absorbing complex - Google Patents
Host-guest enery-absorbing complexInfo
- Publication number
- EP1802961A2 EP1802961A2 EP05798023A EP05798023A EP1802961A2 EP 1802961 A2 EP1802961 A2 EP 1802961A2 EP 05798023 A EP05798023 A EP 05798023A EP 05798023 A EP05798023 A EP 05798023A EP 1802961 A2 EP1802961 A2 EP 1802961A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- complex
- functionality
- analyte
- acid
- host
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000012491 analyte Substances 0.000 claims abstract description 72
- 238000000034 method Methods 0.000 claims abstract description 61
- 238000003795 desorption Methods 0.000 claims abstract description 52
- 229920000858 Cyclodextrin Polymers 0.000 claims description 104
- 239000000523 sample Substances 0.000 claims description 82
- 239000000758 substrate Substances 0.000 claims description 77
- 229920000642 polymer Polymers 0.000 claims description 73
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 68
- 238000009739 binding Methods 0.000 claims description 63
- 230000027455 binding Effects 0.000 claims description 62
- 238000004949 mass spectrometry Methods 0.000 claims description 23
- 125000000217 alkyl group Chemical group 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 16
- 230000002209 hydrophobic effect Effects 0.000 claims description 13
- 239000000178 monomer Substances 0.000 claims description 12
- 230000003993 interaction Effects 0.000 claims description 11
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 claims description 10
- PCMORTLOPMLEFB-ONEGZZNKSA-N sinapic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-ONEGZZNKSA-N 0.000 claims description 10
- 125000004404 heteroalkyl group Chemical group 0.000 claims description 9
- 125000001424 substituent group Chemical group 0.000 claims description 9
- 125000003118 aryl group Chemical group 0.000 claims description 8
- PCMORTLOPMLEFB-UHFFFAOYSA-N sinapinic acid Natural products COC1=CC(C=CC(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-UHFFFAOYSA-N 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 7
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 6
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 claims description 6
- 229920006037 cross link polymer Polymers 0.000 claims description 6
- JVTZFYYHCGSXJV-UHFFFAOYSA-N isovanillin Chemical compound COC1=CC=C(C=O)C=C1O JVTZFYYHCGSXJV-UHFFFAOYSA-N 0.000 claims description 6
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 claims description 6
- AFVLVVWMAFSXCK-UHFFFAOYSA-N α-cyano-4-hydroxycinnamic acid Chemical compound OC(=O)C(C#N)=CC1=CC=C(O)C=C1 AFVLVVWMAFSXCK-UHFFFAOYSA-N 0.000 claims description 5
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 claims description 4
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 claims description 4
- 235000001785 ferulic acid Nutrition 0.000 claims description 4
- 229940114124 ferulic acid Drugs 0.000 claims description 4
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 claims description 4
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 claims description 3
- PLVPPLCLBIEYEA-AATRIKPKSA-N (E)-3-(indol-3-yl)acrylic acid Chemical compound C1=CC=C2C(/C=C/C(=O)O)=CNC2=C1 PLVPPLCLBIEYEA-AATRIKPKSA-N 0.000 claims description 3
- SKZKKFZAGNVIMN-UHFFFAOYSA-N Salicilamide Chemical compound NC(=O)C1=CC=CC=C1O SKZKKFZAGNVIMN-UHFFFAOYSA-N 0.000 claims description 3
- 235000004883 caffeic acid Nutrition 0.000 claims description 3
- 229940074360 caffeic acid Drugs 0.000 claims description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 3
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 claims description 3
- 229960003512 nicotinic acid Drugs 0.000 claims description 3
- 235000001968 nicotinic acid Nutrition 0.000 claims description 3
- 239000011664 nicotinic acid Substances 0.000 claims description 3
- 229960000581 salicylamide Drugs 0.000 claims description 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 2
- 239000004020 conductor Substances 0.000 claims description 2
- 239000002739 cryptand Substances 0.000 claims description 2
- 125000001072 heteroaryl group Chemical group 0.000 claims description 2
- 125000001041 indolyl group Chemical group 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 238000006116 polymerization reaction Methods 0.000 claims description 2
- 125000004076 pyridyl group Chemical group 0.000 claims description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims 4
- SIOXPEMLGUPBBT-UHFFFAOYSA-N picolinic acid Chemical compound OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 claims 4
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 claims 2
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 claims 2
- 235000013985 cinnamic acid Nutrition 0.000 claims 2
- 229930016911 cinnamic acid Natural products 0.000 claims 2
- 125000003700 epoxy group Chemical group 0.000 claims 2
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 claims 2
- 229940081066 picolinic acid Drugs 0.000 claims 2
- LGAILEFNHXWAJP-BMEPFDOTSA-N macrocycle Chemical class N([C@H]1[C@@H](C)CC)C(=O)C(N=2)=CSC=2CNC(=O)C(=C(O2)C)N=C2[C@H]([C@@H](C)CC)NC(=O)C2=CSC1=N2 LGAILEFNHXWAJP-BMEPFDOTSA-N 0.000 claims 1
- 150000002678 macrocyclic compounds Chemical class 0.000 claims 1
- 238000012546 transfer Methods 0.000 abstract description 3
- 239000011159 matrix material Substances 0.000 description 51
- -1 EAM compound Chemical class 0.000 description 38
- 150000002500 ions Chemical class 0.000 description 36
- 239000001116 FEMA 4028 Substances 0.000 description 30
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 30
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 30
- 229960004853 betadex Drugs 0.000 description 30
- 239000007789 gas Substances 0.000 description 28
- 239000012071 phase Substances 0.000 description 28
- 239000000243 solution Substances 0.000 description 27
- 239000003463 adsorbent Substances 0.000 description 25
- 241000894007 species Species 0.000 description 25
- 125000000524 functional group Chemical group 0.000 description 20
- 238000000672 surface-enhanced laser desorption--ionisation Methods 0.000 description 19
- 210000004027 cell Anatomy 0.000 description 17
- 239000003153 chemical reaction reagent Substances 0.000 description 17
- 102000004169 proteins and genes Human genes 0.000 description 17
- 108090000623 proteins and genes Proteins 0.000 description 17
- 239000000126 substance Substances 0.000 description 17
- 230000000295 complement effect Effects 0.000 description 15
- 239000000463 material Substances 0.000 description 15
- 238000002474 experimental method Methods 0.000 description 14
- 150000007523 nucleic acids Chemical class 0.000 description 14
- 210000001519 tissue Anatomy 0.000 description 14
- 238000004458 analytical method Methods 0.000 description 13
- 229940097362 cyclodextrins Drugs 0.000 description 13
- 238000001514 detection method Methods 0.000 description 13
- 108020004707 nucleic acids Proteins 0.000 description 13
- 102000039446 nucleic acids Human genes 0.000 description 13
- 238000001228 spectrum Methods 0.000 description 13
- AFVLVVWMAFSXCK-VMPITWQZSA-N alpha-cyano-4-hydroxycinnamic acid Chemical group OC(=O)C(\C#N)=C\C1=CC=C(O)C=C1 AFVLVVWMAFSXCK-VMPITWQZSA-N 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 12
- 108090000765 processed proteins & peptides Proteins 0.000 description 12
- 239000000725 suspension Substances 0.000 description 12
- 239000007864 aqueous solution Substances 0.000 description 11
- 230000006870 function Effects 0.000 description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- NZNMSOFKMUBTKW-UHFFFAOYSA-N Cyclohexanecarboxylic acid Natural products OC(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-N 0.000 description 10
- 150000001875 compounds Chemical class 0.000 description 10
- 102000004196 processed proteins & peptides Human genes 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 8
- 102000018832 Cytochromes Human genes 0.000 description 8
- 108010052832 Cytochromes Proteins 0.000 description 8
- 150000001412 amines Chemical class 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 238000009826 distribution Methods 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 238000005755 formation reaction Methods 0.000 description 8
- 230000009257 reactivity Effects 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 230000009918 complex formation Effects 0.000 description 7
- 238000000752 ionisation method Methods 0.000 description 7
- 238000001819 mass spectrum Methods 0.000 description 7
- 229910021645 metal ion Inorganic materials 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 125000005842 heteroatom Chemical group 0.000 description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 6
- 229920001184 polypeptide Polymers 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 229920001577 copolymer Polymers 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 238000001616 ion spectroscopy Methods 0.000 description 5
- 125000005647 linker group Chemical group 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- 239000007790 solid phase Substances 0.000 description 5
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 4
- 108090001008 Avidin Proteins 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 229960002685 biotin Drugs 0.000 description 4
- 235000020958 biotin Nutrition 0.000 description 4
- 239000011616 biotin Substances 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 239000002738 chelating agent Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000000536 complexating effect Effects 0.000 description 4
- 239000003431 cross linking reagent Substances 0.000 description 4
- 230000008034 disappearance Effects 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 125000004474 heteroalkylene group Chemical group 0.000 description 4
- 238000005342 ion exchange Methods 0.000 description 4
- 239000003446 ligand Substances 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 238000000059 patterning Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000012265 solid product Substances 0.000 description 4
- 239000011877 solvent mixture Substances 0.000 description 4
- 230000009870 specific binding Effects 0.000 description 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 4
- 229910052717 sulfur Inorganic materials 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 150000001299 aldehydes Chemical group 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 229960001631 carbomer Drugs 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000010668 complexation reaction Methods 0.000 description 3
- 150000003983 crown ethers Chemical class 0.000 description 3
- 238000001212 derivatisation Methods 0.000 description 3
- 150000002118 epoxides Chemical group 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 238000007306 functionalization reaction Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 229920001519 homopolymer Polymers 0.000 description 3
- 239000000017 hydrogel Substances 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000005056 polyisocyanate Substances 0.000 description 3
- 229920001228 polyisocyanate Polymers 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 3
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
- YXIWHUQXZSMYRE-UHFFFAOYSA-N 1,3-benzothiazole-2-thiol Chemical compound C1=CC=C2SC(S)=NC2=C1 YXIWHUQXZSMYRE-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- AOBIOSPNXBMOAT-UHFFFAOYSA-N 2-[2-(oxiran-2-ylmethoxy)ethoxymethyl]oxirane Chemical compound C1OC1COCCOCC1CO1 AOBIOSPNXBMOAT-UHFFFAOYSA-N 0.000 description 2
- BRARRAHGNDUELT-UHFFFAOYSA-N 3-hydroxypicolinic acid Chemical compound OC(=O)C1=NC=CC=C1O BRARRAHGNDUELT-UHFFFAOYSA-N 0.000 description 2
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- 108091023037 Aptamer Proteins 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 108090001090 Lectins Proteins 0.000 description 2
- 102000004856 Lectins Human genes 0.000 description 2
- 108090001030 Lipoproteins Proteins 0.000 description 2
- 102000004895 Lipoproteins Human genes 0.000 description 2
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 229910007161 Si(CH3)3 Inorganic materials 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 2
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- 125000000304 alkynyl group Chemical group 0.000 description 2
- 150000001408 amides Chemical group 0.000 description 2
- 238000005349 anion exchange Methods 0.000 description 2
- NUZWLKWWNNJHPT-UHFFFAOYSA-N anthralin Chemical compound C1C2=CC=CC(O)=C2C(=O)C2=C1C=CC=C2O NUZWLKWWNNJHPT-UHFFFAOYSA-N 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- VTJUKNSKBAOEHE-UHFFFAOYSA-N calixarene Chemical compound COC(=O)COC1=C(CC=2C(=C(CC=3C(=C(C4)C=C(C=3)C(C)(C)C)OCC(=O)OC)C=C(C=2)C(C)(C)C)OCC(=O)OC)C=C(C(C)(C)C)C=C1CC1=C(OCC(=O)OC)C4=CC(C(C)(C)C)=C1 VTJUKNSKBAOEHE-UHFFFAOYSA-N 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical group 0.000 description 2
- 150000001793 charged compounds Chemical class 0.000 description 2
- 239000013522 chelant Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 150000005690 diesters Chemical class 0.000 description 2
- 125000005442 diisocyanate group Chemical group 0.000 description 2
- 150000002009 diols Chemical class 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 150000002019 disulfides Chemical class 0.000 description 2
- 229960002311 dithranol Drugs 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 238000002848 electrochemical method Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000009499 grossing Methods 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 125000001188 haloalkyl group Chemical group 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 230000003100 immobilizing effect Effects 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 238000001698 laser desorption ionisation Methods 0.000 description 2
- 239000002523 lectin Substances 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 238000002493 microarray Methods 0.000 description 2
- 238000000813 microcontact printing Methods 0.000 description 2
- 230000009149 molecular binding Effects 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 230000009871 nonspecific binding Effects 0.000 description 2
- 239000011368 organic material Substances 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229960003330 pentetic acid Drugs 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000000206 photolithography Methods 0.000 description 2
- 238000004375 physisorption Methods 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000012465 retentate Substances 0.000 description 2
- SMQUZDBALVYZAC-UHFFFAOYSA-N salicylaldehyde Chemical compound OC1=CC=CC=C1C=O SMQUZDBALVYZAC-UHFFFAOYSA-N 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 238000001542 size-exclusion chromatography Methods 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 239000001384 succinic acid Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 150000007970 thio esters Chemical class 0.000 description 2
- 125000003396 thiol group Chemical group [H]S* 0.000 description 2
- 230000036962 time dependent Effects 0.000 description 2
- 238000001269 time-of-flight mass spectrometry Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 230000001173 tumoral effect Effects 0.000 description 2
- 125000004417 unsaturated alkyl group Chemical group 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- SYFQYGMJENQVQT-ZETCQYMHSA-N (2s)-6-amino-2-[bis(carboxymethyl)amino]hexanoic acid Chemical compound NCCCC[C@@H](C(O)=O)N(CC(O)=O)CC(O)=O SYFQYGMJENQVQT-ZETCQYMHSA-N 0.000 description 1
- JDRQGYPSCQVCNF-UHFFFAOYSA-N (pyridin-2-ylmethylamino) acetate Chemical compound CC(=O)ONCC1=CC=CC=N1 JDRQGYPSCQVCNF-UHFFFAOYSA-N 0.000 description 1
- 125000000196 1,4-pentadienyl group Chemical group [H]C([*])=C([H])C([H])([H])C([H])=C([H])[H] 0.000 description 1
- ZVDJGAZWLUJOJW-UHFFFAOYSA-N 1-(4-ethenylphenyl)ethyl-trimethoxysilane Chemical compound CO[Si](OC)(OC)C(C)C1=CC=C(C=C)C=C1 ZVDJGAZWLUJOJW-UHFFFAOYSA-N 0.000 description 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical class C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- XLEYFDVVXLMULC-UHFFFAOYSA-N 2',4',6'-trihydroxyacetophenone Chemical compound CC(=O)C1=C(O)C=C(O)C=C1O XLEYFDVVXLMULC-UHFFFAOYSA-N 0.000 description 1
- 229940054266 2-mercaptobenzothiazole Drugs 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- SVNCRRZKBNSMIV-UHFFFAOYSA-N 3-Aminoquinoline Chemical compound C1=CC=CC2=CC(N)=CN=C21 SVNCRRZKBNSMIV-UHFFFAOYSA-N 0.000 description 1
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
- CSBJCQMIXISILC-UHFFFAOYSA-N 3-[chloro(dimethyl)silyl]propyl prop-2-enoate Chemical compound C[Si](C)(Cl)CCCOC(=O)C=C CSBJCQMIXISILC-UHFFFAOYSA-N 0.000 description 1
- QXKMQBOTKLTKOE-UHFFFAOYSA-N 3-[dichloro(methyl)silyl]propyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCC[Si](C)(Cl)Cl QXKMQBOTKLTKOE-UHFFFAOYSA-N 0.000 description 1
- GBAQKTTVWCCNHH-UHFFFAOYSA-N 3-[dichloro(methyl)silyl]propyl prop-2-enoate Chemical compound C[Si](Cl)(Cl)CCCOC(=O)C=C GBAQKTTVWCCNHH-UHFFFAOYSA-N 0.000 description 1
- LZMNXXQIQIHFGC-UHFFFAOYSA-N 3-[dimethoxy(methyl)silyl]propyl 2-methylprop-2-enoate Chemical compound CO[Si](C)(OC)CCCOC(=O)C(C)=C LZMNXXQIQIHFGC-UHFFFAOYSA-N 0.000 description 1
- MCDBEBOBROAQSH-UHFFFAOYSA-N 3-[dimethoxy(methyl)silyl]propyl prop-2-enoate Chemical compound CO[Si](C)(OC)CCCOC(=O)C=C MCDBEBOBROAQSH-UHFFFAOYSA-N 0.000 description 1
- JBDMKOVTOUIKFI-UHFFFAOYSA-N 3-[methoxy(dimethyl)silyl]propyl 2-methylprop-2-enoate Chemical compound CO[Si](C)(C)CCCOC(=O)C(C)=C JBDMKOVTOUIKFI-UHFFFAOYSA-N 0.000 description 1
- ZCRUJAKCJLCJCP-UHFFFAOYSA-N 3-[methoxy(dimethyl)silyl]propyl prop-2-enoate Chemical compound CO[Si](C)(C)CCCOC(=O)C=C ZCRUJAKCJLCJCP-UHFFFAOYSA-N 0.000 description 1
- 125000000474 3-butynyl group Chemical group [H]C#CC([H])([H])C([H])([H])* 0.000 description 1
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 1
- UDNJYKOKKPNOGQ-UHFFFAOYSA-N 3-silyloxy-N-(3-silyloxypropyl)propan-1-amine Chemical compound [SiH3]OCCCNCCCO[SiH3] UDNJYKOKKPNOGQ-UHFFFAOYSA-N 0.000 description 1
- DOGMJCPBZJUYGB-UHFFFAOYSA-N 3-trichlorosilylpropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCC[Si](Cl)(Cl)Cl DOGMJCPBZJUYGB-UHFFFAOYSA-N 0.000 description 1
- LEPRPXBFZRAOGU-UHFFFAOYSA-N 3-trichlorosilylpropyl prop-2-enoate Chemical compound Cl[Si](Cl)(Cl)CCCOC(=O)C=C LEPRPXBFZRAOGU-UHFFFAOYSA-N 0.000 description 1
- TZZGHGKTHXIOMN-UHFFFAOYSA-N 3-trimethoxysilyl-n-(3-trimethoxysilylpropyl)propan-1-amine Chemical compound CO[Si](OC)(OC)CCCNCCC[Si](OC)(OC)OC TZZGHGKTHXIOMN-UHFFFAOYSA-N 0.000 description 1
- SJECZPVISLOESU-UHFFFAOYSA-N 3-trimethoxysilylpropan-1-amine Chemical compound CO[Si](OC)(OC)CCCN SJECZPVISLOESU-UHFFFAOYSA-N 0.000 description 1
- XDLMVUHYZWKMMD-UHFFFAOYSA-N 3-trimethoxysilylpropyl 2-methylprop-2-enoate Chemical compound CO[Si](OC)(OC)CCCOC(=O)C(C)=C XDLMVUHYZWKMMD-UHFFFAOYSA-N 0.000 description 1
- KBQVDAIIQCXKPI-UHFFFAOYSA-N 3-trimethoxysilylpropyl prop-2-enoate Chemical compound CO[Si](OC)(OC)CCCOC(=O)C=C KBQVDAIIQCXKPI-UHFFFAOYSA-N 0.000 description 1
- TYMLOMAKGOJONV-UHFFFAOYSA-N 4-nitroaniline Chemical compound NC1=CC=C([N+]([O-])=O)C=C1 TYMLOMAKGOJONV-UHFFFAOYSA-N 0.000 description 1
- CDWGDLKZKCYUFO-UHFFFAOYSA-N 6-(trifluoromethyl)-1h-indole-2-carboxylic acid Chemical compound C1=C(C(F)(F)F)C=C2NC(C(=O)O)=CC2=C1 CDWGDLKZKCYUFO-UHFFFAOYSA-N 0.000 description 1
- 239000005725 8-Hydroxyquinoline Substances 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 239000005047 Allyltrichlorosilane Substances 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 102000003846 Carbonic anhydrases Human genes 0.000 description 1
- 108090000209 Carbonic anhydrases Proteins 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- HQNJUACUCOKKNB-UHFFFAOYSA-N Cl[Si](Cl)(Cl)[ClH]C(C)CCCCC=C Chemical compound Cl[Si](Cl)(Cl)[ClH]C(C)CCCCC=C HQNJUACUCOKKNB-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 description 1
- 238000005698 Diels-Alder reaction Methods 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 239000004593 Epoxy Chemical group 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical group OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 102000007625 Hirudins Human genes 0.000 description 1
- 108010007267 Hirudins Proteins 0.000 description 1
- VSNHCAURESNICA-UHFFFAOYSA-N Hydroxyurea Chemical compound NC(=O)NO VSNHCAURESNICA-UHFFFAOYSA-N 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 206010065973 Iron Overload Diseases 0.000 description 1
- YIVJZNGAASQVEM-UHFFFAOYSA-N Lauroyl peroxide Chemical compound CCCCCCCCCCCC(=O)OOC(=O)CCCCCCCCCCC YIVJZNGAASQVEM-UHFFFAOYSA-N 0.000 description 1
- 238000006845 Michael addition reaction Methods 0.000 description 1
- 102000036675 Myoglobin Human genes 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical class ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 1
- BVMWIXWOIGJRGE-UHFFFAOYSA-N NP(O)=O Chemical class NP(O)=O BVMWIXWOIGJRGE-UHFFFAOYSA-N 0.000 description 1
- JZFPYUNJRRFVQU-UHFFFAOYSA-N Niflumic acid Chemical class OC(=O)C1=CC=CN=C1NC1=CC=CC(C(F)(F)F)=C1 JZFPYUNJRRFVQU-UHFFFAOYSA-N 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- 102000012288 Phosphopyruvate Hydratase Human genes 0.000 description 1
- 108010022181 Phosphopyruvate Hydratase Proteins 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- HRSANNODOVBCST-UHFFFAOYSA-N Pronethalol Chemical compound C1=CC=CC2=CC(C(O)CNC(C)C)=CC=C21 HRSANNODOVBCST-UHFFFAOYSA-N 0.000 description 1
- 102000004389 Ribonucleoproteins Human genes 0.000 description 1
- 108010081734 Ribonucleoproteins Proteins 0.000 description 1
- 229910008051 Si-OH Inorganic materials 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 229910006358 Si—OH Inorganic materials 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000011358 absorbing material Substances 0.000 description 1
- GTDPSWPPOUPBNX-UHFFFAOYSA-N ac1mqpva Chemical compound CC12C(=O)OC(=O)C1(C)C1(C)C2(C)C(=O)OC1=O GTDPSWPPOUPBNX-UHFFFAOYSA-N 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 150000001266 acyl halides Chemical class 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 125000005041 acyloxyalkyl group Chemical group 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000005237 alkyleneamino group Chemical group 0.000 description 1
- 125000005238 alkylenediamino group Chemical group 0.000 description 1
- 125000005530 alkylenedioxy group Chemical group 0.000 description 1
- 125000005529 alkyleneoxy group Chemical group 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 238000004082 amperometric method Methods 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 238000004630 atomic force microscopy Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical group C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 230000005255 beta decay Effects 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 210000003443 bladder cell Anatomy 0.000 description 1
- 210000005068 bladder tissue Anatomy 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 238000005341 cation exchange Methods 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000003486 chemical etching Methods 0.000 description 1
- 238000000451 chemical ionisation Methods 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 150000004696 coordination complex Chemical class 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- XLJMAIOERFSOGZ-UHFFFAOYSA-M cyanate group Chemical group [O-]C#N XLJMAIOERFSOGZ-UHFFFAOYSA-M 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000006352 cycloaddition reaction Methods 0.000 description 1
- 125000000392 cycloalkenyl group Chemical group 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- XCSQXCKDEVRTHN-UHFFFAOYSA-N cyclohexa-1,4-diene-1-carboxylic acid Chemical compound OC(=O)C1=CCC=CC1 XCSQXCKDEVRTHN-UHFFFAOYSA-N 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 1
- 229960002887 deanol Drugs 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical class OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 1
- 125000004990 dihydroxyalkyl group Chemical group 0.000 description 1
- 239000012972 dimethylethanolamine Substances 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 238000000572 ellipsometry Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 125000002573 ethenylidene group Chemical group [*]=C=C([H])[H] 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000010265 fast atom bombardment Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 229910052733 gallium Inorganic materials 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 150000005694 halopyrimidines Chemical class 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 125000004366 heterocycloalkenyl group Chemical group 0.000 description 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 description 1
- 238000012203 high throughput assay Methods 0.000 description 1
- 238000013537 high throughput screening Methods 0.000 description 1
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 description 1
- 229940006607 hirudin Drugs 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 150000007857 hydrazones Chemical class 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 150000002433 hydrophilic molecules Chemical class 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- NBZBKCUXIYYUSX-UHFFFAOYSA-N iminodiacetic acid Chemical compound OC(=O)CNCC(O)=O NBZBKCUXIYYUSX-UHFFFAOYSA-N 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000005305 interferometry Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000005040 ion trap Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- VDBNYAPERZTOOF-UHFFFAOYSA-N isoquinolin-1(2H)-one Chemical compound C1=CC=C2C(=O)NC=CC2=C1 VDBNYAPERZTOOF-UHFFFAOYSA-N 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 210000003563 lymphoid tissue Anatomy 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000007620 mathematical function Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 125000005641 methacryl group Chemical group 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000000615 nonconductor Substances 0.000 description 1
- 238000001668 nucleic acid synthesis Methods 0.000 description 1
- 239000012038 nucleophile Substances 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- 229960003540 oxyquinoline Drugs 0.000 description 1
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000003094 perturbing effect Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 238000001259 photo etching Methods 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical group 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 210000004908 prostatic fluid Anatomy 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 1
- 238000006268 reductive amination reaction Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000005084 renal tissue Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000001004 secondary ion mass spectrometry Methods 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 150000007659 semicarbazones Chemical class 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 125000005504 styryl group Chemical group 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 125000002128 sulfonyl halide group Chemical group 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 1
- 238000001920 surface-enhanced laser desorption--ionisation mass spectrometry Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 150000005621 tetraalkylammonium salts Chemical class 0.000 description 1
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
- 125000005309 thioalkoxy group Chemical group 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 150000003573 thiols Chemical group 0.000 description 1
- 150000003585 thioureas Chemical class 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- PHPGQFXPRCRKSF-UHFFFAOYSA-N trichloro(4-phenylbut-3-enyl)silane Chemical compound Cl[Si](Cl)(Cl)CCC=CC1=CC=CC=C1 PHPGQFXPRCRKSF-UHFFFAOYSA-N 0.000 description 1
- HKFSBKQQYCMCKO-UHFFFAOYSA-N trichloro(prop-2-enyl)silane Chemical compound Cl[Si](Cl)(Cl)CC=C HKFSBKQQYCMCKO-UHFFFAOYSA-N 0.000 description 1
- SEAZOECJMOZWTD-UHFFFAOYSA-N trimethoxy(oxiran-2-ylmethyl)silane Chemical compound CO[Si](OC)(OC)CC1CO1 SEAZOECJMOZWTD-UHFFFAOYSA-N 0.000 description 1
- 150000003672 ureas Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000004832 voltammetry Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
Definitions
- Laser desorption/ionization time-of-flight mass spectrometry is a popular method for analyzing biological molecules such as polypeptides and nucleic acids.
- the sample to be analyzed is deposited on a solid substrate, referred to as a probe or a target.
- Pulses of laser energy are directed against a substrate-bound sample.
- the laser energy causes the sample molecules to desorb from the probe surface and become ionized.
- the ion optics of a time-of-flight instrument accelerate the ionized molecules into a free flight tube, where they separate according to mass, and are detected with particle detector.
- Analytes having masses above about 2500 Daltons tend to fragment when struck directly by a laser.
- MALDI matrix assisted laser desorption/ionization
- the sample is associated on the probe surface with molecules that absorb the laser light and promote desorption/ionization of substantially intact large biomolecules.
- Typical laser energy absorbing molecules include sinapinic acid, alpha-cyano- hydroxycinammic acid, 2,5 dihydrobenzoic acid and ferulic acid.
- the sample and the laser energy absorbing molecules are intimately mixed and placed on the probe surface to dry, so that the two co-crystallize. In such a case, the energy absorbing molecules are referred to as "matrix.”
- the energy absorbing molecules tends to be a hydrophobic species
- many analytes of interest are water-soluble molecules, e.g., peptides, nucleic acids, saccharides.
- the difference in polarities of the energy absorbing molecule, the analyte and the solvents used for both of these elements, can result in a matrix in which the energy absorbing moleculedistributes into "islands" of irregularly sized crystals.
- the matrix is merely "laid down" on the chip, it is challenging to wash away contaminants in the analyte or matrix without perturbing or washing away the matrix.
- Hutchens and Yip described an LDI method in which the analyte molecules were not co-crystallized with the energy absorbing molecules. (WO 94/02814.) They referred to the method as SEND.
- SEND the energy absorbing molecules, referred to there as "EAMs,” were covalently coupled to the probe surface, and the analyte molecules were deposited upon them.
- SEND was further refined by Kitagawa who proposed the incorporation of energy absorbing molecules into polymers that were, themselves, deposited on the probe surface. See, for example, U.S. Patent Publication 03/0207460, "Monomers And Polymers Having
- Kitagawa method was the decrease in signal from desorbed energy absorbing molecules, which creates noise in the low mass range in MALDI.
- a surface combining the advantages of a surface-associtated matrix with the flexibility to alter both the EAM identity and amount according to the parameters of a particular analysis would represent a significant advance in the art.
- An exemplary surface would incorporate a moiety that interacts non-covalently with an EAM.
- Such a matrix could be based upon an EAM, including those currently recognized, that does not require derivatization to allow its incorporation into the surface.
- a surface that provides a receptacle for an EAM would notably simplify the manufacture of EAM-containing surfaces and analytical devices employing these surfaces.
- a matrix that did not require a dry down period and, thus, was of use in high-throughput analyses would greatly speed data acquisition from laser desorption mass spectrometric analyses.
- a host-guest complex formed between a molecular host and an EAM transfers energy to an analyte, desorbing the analyte from a surface that includes the complex and ionizing the analyte.
- the discovery provides access to surfaces and devices incorporating these surfaces that mitigate many of the shortcomings of prior surfaces and devices for use in laser desorption/ionization mass spectrometry.
- the surfaces and devices of the invention provide analytical formats that were not previously available.
- the present invention provides a surface that includes a matrix that is both readily reproducible and tunable.
- the matrix is tuned by varying the structure and amount of EAM complexed with the molecular host, providing unparalleled flexibility in the design of a matrix for a selected application.
- the complexes, surfaces and devices of the invention provide numerous other advantages.
- surfaces that include host-guest EAM complexes provide improved washability.
- EAM is trapped inside the cavity of a host, so the surface can be subjected to intensive washing with buffer solution to remove salts and impurities without losing EAM from the surface.
- the physiochemical properties of EAM matrices, such as solubility and stability can be altered through their formation of inclusion complexes with host.
- surfaces that include host- guest EAM complexes are well suited for analyses that require the use of water in the presence of the hydrophobic EAM; as the distribution of the EAM is a function of the molecular host, the presence of water on the surface does not adversely affect EAM distribution.
- the use of host-guest complexes promotes the controlled distribution of the EAM on the surface, remedying the uneven distribution of EAM that is a common problem with application of an excess of EAM in a solvent that is essentially incompatible with the analyte.
- the invention also provides access to volatile matrices that used to be disqualified as EAM. For SELDI and MALDI applications, a matrix needs to be stable under vacuum for extended periods of time without being sublimated away.
- High throughput assays are of particular value and relevance in a number of fields, e.g., proteomics, and drug discovery. Tools for use in high throughput analyses are preferably characterized by uniformity and reproducibility in their structure and function.
- the complexes, surfaces and devices of the present invention are of particular use in high throughput screening. By providing a surface that eliminates the need to mix the sample with the matrix and dry the matrix on the surface, the present invention provides a surface, and devices incorporating that surface, that are quickly and reproducibly prepared.
- the invention also provides surfaces and devices incorporating these surfaces in which the host molecule is not complexed with the EAM.
- the uncomplexed host can be contacted with a selected EAM, thereby forming the complex.
- the invention provides a host-guest complex that includes a molecular host complexed with an energy absorbing molecule that absorbs energy from a photo-irradiation source and thereby contributes to desorption and ionization of analyte molecules in operative contact therewith.
- the complex is immobilized on a substrate that is a component of a probe for a mass spectrometer, e.g., a substrate that includes a means for engaging a probe interface of a mass spectrometer.
- the EAM-host complex is essentially water-soluble, or at least more water-soluble than the EAM alone.
- the invention provides the first essentially water-soluble matrix for use in laser desorption/ionization mass spectrometry.
- an aqueous solution of the water-soluble matrix can be laid down on the analyte in a manner analogous to that presently used with EAM solutions in organic solvent.
- the host-guest complex is attached to a substrate, forming a surface on the substrate. The complex can be attached to the substrate at a plurality of addressable locations.
- An exemplary surface of the invention is an adsorbent surface, also referred to herein as an "adsorbent film.”
- An adsorbent film of the invention is generally a polymer formed between a polymerizable analogue of the host and a polymerizable monomer that includes a binding functionality.
- the molecular host includes a binding functionality, through which a population of the host molecules binds an analyte.
- the functionalized host may also complex an EAM; alternatively, the EAM is complexed by a population of non- functionalized host molecules.
- Exemplary binding functionalities appended to the host or polymerizable monomer include a hydrophobic group, a hydrophilic group, reactive groups such as aldehydes, epoxy, carbonates, thiols and the like; ion exchange moieties, e.g., a carboxyl, a sulfonate, a sulfate, an amino, a substituted amino, a phosphate; a metal chelating group; a thioether, a biotin, a boronate, and other structures such as dyes, nucleic acids, and peptides.
- Exemplary molecular hosts include a macrocyclic species, such a crown ether, calixarene, spherand, cavitand and cyclodextrin.
- a macrocyclic species such as a crown ether, calixarene, spherand, cavitand and cyclodextrin.
- the cyclodextrin or its EAM complex may be simply deposited onto a device of the invention or it can be attached to the substrate through a species such as an anchor moiety.
- a representative anchor moiety is formed by reaction of a reactive functionality on an anchor reagent with a reactive functionality of complementary reactivity on the cyclodextrin.
- the cyclodextrin is utilized as a monomer, a homopolymer or a copolymer with one or more monomers having a useful property, e.g. the presence of a binding functionality.
- the cyclodextrin-containing polymer is optionally cross- linked.
- the cyclodextrin-EAM complex provides access to novel surfaces and devices and means to incorporate into a device, e.g., a chip, an energy absorbing matrix useful in one or more laser desorption/ionization mass spectrometric analytical technique.
- the cavity of the cyclodextrin has properties that are well suited to interaction with the essentially hydrophobic species upon which most art-recognized matrix molecules are based.
- the inclusion of the matrix molecule into the cyclodextrin cavity in a host-guest complex eliminates the need to crystallize the hydrophobic matrix on a sample adsorbed onto a chip.
- the geometric regularity of the cyclodextrin cavity results in matrix components of essentially identical size.
- standard methods of crystallizing the matrix species on the adsorbed sample result in ranges of crystal sizes that can have a deleterious impact on the subsequent mass spectrometric analysis.
- the cyclodextrin-EAM complex is an exemplary water-soluble matrix of the invention.
- the cyclodextrin-EAM complex when the surface is anchored to a substrate, provides a matrix in which multiple EAM are confined to specific, predictable and reproducibly accessed regions of the surface, i.e., the cyclodextrin cavity, providing a reproducible distribution of the EAM on the surface.
- the reproducibility of EAM distribution is in distinct contrast to methods in which a water-insoluble matrix is crystallized on the sample; phenomena such as clumping or segregation of the crystals in unrepeatable "island" formations on the surface is avoided.
- the reversible nature of the complexation of the EAM by cyclodextrin allows the loading/unloading of EAM in the host to be manipulated by a variety of methods, e.g., controlling the polarity of a solvent in contact with the complex.
- a solvent in contact with the complex.
- contacting the matrix with water will tend to drive the EAM into the cyclodextrin cavity.
- treating the matrix with an organic solvent will tend to extract the complexed EAM out of the cyclodextrin cavity.
- An exemplary cyclodextrin-containing surface of the invention is an "adsorbent film," capable of immobilizing an analyte.
- the film, and thus the device is capable of selectively binding one or more analyte from a sample.
- a film includes a cyclodextrin monomer, or a cyclodextrin-containing polymer, and the film is attached to the surface of a substrate.
- a component of the film may include one or more binding functionality.
- An array of modalities is available for attaching film components to a substrate surface.
- the attachment is by means of a covalent bond formed between moieties of complementary reactivity on the adsorbent film and on an anchor reagent.
- the invention provides a cyclodextrin- containing adsorbent film that is grafted to the substrate surface through a chemical reaction that forms a covalent bond.
- the film can be a hydrogel.
- FIG. 1 shows the complexation of a representative EAM compound by a cyclodextrin.
- FIG. 2 is an illustration of constructing cross-linked CD-containing polymer on a chip surface using a cyanate moiety.
- FIG. 3 is an illustration of constructing cross-linked CD-containing polymer on a chip surface using an epoxide moiety.
- FIG. 4 is a mass spectrum of cytochrome C acquired using 1.2 ⁇ L of SPA/ ⁇ - cyclodextrin matrix complex solution to assist the desorption and ionization process under typical laser condition.
- FIG. 5 is a mass spectrum of cytochrome C acquired using 4 ⁇ L of SPA/ ⁇ - cyclodextrin matrix complex solution to assist the desorption and ionization process under typical laser condition.
- FIG. 6 is a mass spectrum of ALL-in-1 protein profile in the mass range of 5,000- 70,000 Daltons acquired using SPA/ ⁇ -cyclodextrin polymer matrix complex to assist the desorption and ionization process under typical laser condition.
- FIG. 7 shows an exemplary anchor reagent.
- FIG. 8 shows an exemplary anchor reagent coupled to a glass surface.
- FIG. 9 displays an array of exemplary functionalization chemistries for incorporating binding functionalities into cyclodextrin or a cyclodextrin-containing polymer.
- FIG. 10 is a representative probe format of use in practicing the invention.
- host and "molecular host” refer, essentially interchangeably, to a molecule that surrounds or partially surrounds and attractively interacts with a molecular “guest.”
- guest When the "host” and “guest” interact the resulting species is referred to herein as a "complex.”
- substituent groups are specified by their conventional chemical formulae, written from left to right, they equally encompass the chemically identical substituents which would result from writing the structure from right to left, e.g., -CH 2 O- is intended to also recite -OCH 2 -; -NHS(O) 2 - is also intended to represent. -S(O) 2 HN-, etc.
- alkyl by itself or as part of another substituent, means, unless otherwise stated, a straight or branched chain, or cyclic hydrocarbon radical, or combination thereof, which may be fully saturated, mono- or polyunsaturated and can include di- and multivalent radicals, having the number of carbon atoms designated (i.e. C 1 -C 10 means one to ten carbons).
- saturated hydrocarbon radicals include, but are not limited to, groups such as methyl, ethyl, n-propyl, isopropyl, n-butyl, t-butyl, isobutyl, sec-butyl, cyclohexyl, (cyclohexyl)methyl, cyclopropylmethyl, homologs and isomers of, for example, n-pentyl, n-hexyl, n-heptyl, n-octyl, and the like.
- An unsaturated alkyl group is one having one or more double bonds or triple bonds.
- alkyl groups examples include, but are not limited to, vinyl, 2-propenyl, crotyl, 2-isopentenyl, 2-(butadienyl), 2,4-pentadienyl, 3- (1,4-pentadienyl), ethynyl, 1- and 3-propynyl, 3-butynyl, and the higher homologs and isomers.
- alkyl unless otherwise noted, is also meant to include those derivatives of alkyl defined in more detail below, such as “heteroalkyl.”
- Alkyl groups, which are limited to hydrocarbon groups are termed "homoalkyl".
- heteroalkyl by itself or in combination with another term, means, unless otherwise stated, a stable straight or branched chain, or cyclic hydrocarbon radical, or combinations thereof, consisting of the stated number of carbon atoms and at least one heteroatom selected from the group consisting of O, N, Si and S, and wherein the nitrogen and sulfur atoms may optionally be oxidized and the nitrogen heteroatom may optionally be quaternized.
- the heteroatom(s) O, N and S and Si may be placed at any interior position of the heteroalkyl group or at the position at which the alkyl group is attached to the remainder of the molecule.
- heteroalkylene by itself or as part of another substituent means a divalent radical derived from heteroalkyl, as exemplified, but not limited by, -CH 2 - CH 2 -S-CH 2 -CH 2 - and -CH 2 -S-CH 2 -CH 2 -NH-CH 2 -.
- heteroatoms can also occupy either or both of the chain termini (e.g., alkyleneoxy, alkylenedioxy, alkyleneamino, alkylenediamino, and the like). Still further, for alkylene and heteroalkylene linking groups, no orientation of the linking group is implied by the direction in which the formula of the linking group is written. For example, the formula -C(O) 2 R'- represents both -C(O) 2 R'- and -R 5 C(O) 2 -.
- R 5 , R 55 , R 555 and R 55 each preferably independently refer to hydrogen, substituted or unsubstituted heteroalkyl, substituted or unsubstituted aryl, e.g., aryl substituted with 1-3 halogens, substituted or unsubstituted alkyl, alkoxy or thioalkoxy groups, or arylalkyl groups.
- each of the R groups is independently selected as are each R 5 , R 5 ', R'" and R 55 " groups when more than one of these groups is present.
- R 5 and R" are attached to the same nitrogen atom, they can be combined with the nitrogen atom to form a 5-, 6-, or 7-membered ring.
- -NR'R is meant to include, but not be limited to, 1-pyrrolidinyl and 4-morpholinyl.
- acyl e.g. , -C(O)CH 3 , -C(O)CF 3 , -C(O)CH 2 OCH 3 , and the like).
- heteroatom is meant to include oxygen (O), nitrogen (N), sulfur (S) and silicon (Si).
- Binding functionality means a moiety, which has an affinity for a certain substance such as a "substance to be assayed,” that is, a moiety capable of interacting with a specific substance to immobilize it on an adsorbent material of the invention. Binding functionalities can be chromatographic or biospecific. Chromatographic binding functionalities bind substances via charge-charge, hydrophilic-hydrophilic, hydrophobic- hydrophobic, van der Waals interactions and combinations thereof. Biospecific binding functionalities generally involve complementary 3 -dimensional structures involving one or more of the above interactions.
- biospecific interactions include, but are not limited to, antigens with corresponding antibody molecules, a nucleic acid sequence with its complementary sequence, effector molecules with receptor molecules, enzymes with inhibitors, sugar chain-containing compounds with lectins, an antibody molecule with another antibody molecule specific for the former antibody, receptor molecules with corresponding antibody molecules and the like combinations.
- specific binding substances include a chemically biotin-modified antibody molecule or polynucleotide with avidin, an avidin-bound antibody molecule with biotin and the like combinations.
- Molecular binding partners and “specific binding partners” refer to pairs of molecules, typically pairs of biomolecules that exhibit specific binding. Molecular binding partners include, without limitation, receptor and ligand, antibody and antigen, biotin and avidin, and biotin and streptavidin.
- Adsorbent film as used herein means an area where a substance to be assayed is immobilized and a specific binding reaction occurs. The reaction optionally has a distribution along the flow direction of a test sample.
- polymer and “polymers” include “copolymer” and “copolymers,” and are used interchangeably with the terms “oligomer” and “oligomers.”
- Attached encompasses interaction including, but not limited to, covalent bonding, ionic bonding, chemisorption, physisorption and combinations thereof.
- Analyte refers to any component of a sample that is desired to be detected. The term can refer to a single component or a plurality of components in the sample. Analytes include, for example, biomolecules. Biomolecules can be sourced from any biological material.
- Biomolecule or "bioorganic molecule” refers to an organic molecule typically made by living organisms. This includes, for example, molecules comprising nucleotides, amino acids, sugars, fatty acids, steroids, nucleic acids, polypeptides, peptides, peptide fragments, carbohydrates, lipids, and combinations of these (e.g., glycoproteins, ribonucleoproteins, lipoproteins, or the like).
- Bio material refers to any material derived from an organism, organ, tissue, cell or virus. This includes biological fluids such as saliva, blood, urine, lymphatic fluid, prostatic or seminal fluid, milk, etc., as well as extracts of any of these, e.g., cell extracts or lysates (from, e.g., primary tissue or cells, cultured tissue or cells, normal tissue or cells, diseased tissue or cells, benign tissue or cells, cancerous tissue or cells, salivary glandular tissue or cells, intestinal tissue or cells, neural tissue or cells, renal tissue or cells, lymphatic tissue or cells, bladder tissue or cells, prostatic tissue or cells, urogenital tissues or cells, tumoral tissue or cells, tumoral neovasculature tissue or cells, or the like), cell culture media, fractionated samples (e.g., serum or plasma), or the like.
- cell lysate samples are optionally derived.
- Gas phase ion spectrometer refers to an apparatus that detects gas phase ions.
- Gas phase ion spectrometers include an ion source that supplies gas phase ions.
- Gas phase ion spectrometers include, for example, mass spectrometers, ion mobility spectrometers, and
- Gas phase ion spectrometry refers to the use of a gas phase ion spectrometer to detect gas phase ions.
- Mass spectrometer refers to a gas phase ion spectrometer that measures a parameter that can be translated into mass-to-charge ratios of gas phase ions.
- Mass spectrometers generally include an ion source and a mass analyzer. Examples of mass spectrometers are time-of-flight, magnetic sector, quadrupole filter, ion trap, ion cyclotron resonance, electrostatic sector analyzer and hybrids of these.
- Mass spectrometry refers to the use of a mass spectrometer to detect gas phase ions.
- Laser desorption mass spectrometer refers to a mass spectrometer that uses laser energy as a means to desorb, volatilize, and ionize an analyte.
- Mass analyzer refers to a sub-assembly of a mass spectrometer that comprises means for measuring a parameter that can be translated into mass-to-charge ratios of gas phase ions.
- the mass analyzer comprises an ion optic assembly, a flight tube and an ion detector.
- Ion source refers to a sub-assembly of a gas phase ion spectrometer that i provides gas phase ions. In one embodiment, the ion source provides ions through a desorption/ionization process.
- Such embodiments generally comprise a probe interface that positionally engages a probe in an interrogatable relationship to a source of ionizing energy (e.g., a laser desorption/ionization source) and in concurrent communication at atmospheric or subatmospheric pressure with a detector of a gas phase ion spectrometer.
- a source of ionizing energy e.g., a laser desorption/ionization source
- Forms of ionizing energy for desorbing/ionizing an analyte from a solid phase include, for example: (1) laser energy; (2) fast atoms (used in fast atom bombardment); (3) high energy particles generated via beta decay of radionucleides (used in plasma desorption); and (4) primary ions generating secondary ions (used in secondary ion mass spectrometry).
- the preferred form of ionizing energy for solid phase analytes is a laser (used in laser desorption/ionization), in particular, nitrogen lasers, Nd- Yag lasers and other pulsed laser sources.
- “Fluence” refers to the energy delivered per unit area of interrogated image.
- a high fluence source such as a laser, will deliver about 1 mJ / mm 2 to about 50 mJ / mm 2 .
- a sample is placed on the surface of a probe, the probe is engaged with the probe interface and the probe surface is exposed to the ionizing energy. The energy desorbs analyte molecules from the surface into the gas phase and ionizes them.
- ionizing energy for analytes include, for example: (1) electrons that ionize gas phase neutrals; (2) strong electric field to induce ionization from gas phase, solid phase, or liquid phase neutrals; and (3) a source that applies a combination of ionization particles or electric fields with neutral chemicals to induce chemical ionization of solid phase, gas phase, and liquid phase neutrals.
- SELDI surface-enhanced laser desorption/ionization
- gas phase ion spectrometry e.g., mass spectrometry
- SELDI MS the gas phase ion spectrometer is a mass spectrometer.
- SELDI technology is described in, e.g., U.S. patent 5,719,060 (Hutchens and Yip) and U.S. patent 6,225,047 (Hutchens and Yip).
- SEEC Surface-Enhanced Affinity Capture
- affinity gas phase ion spectrometry e.g., affinity mass spectrometry
- SELDI probe an absorbent surface
- Adsorbent surface refers to a sample presenting surface of a probe to which an adsorbent (also called a “capture reagent” or an “affinity reagent") is attached.
- An adsorbent is any material capable of binding an analyte (e.g., a target polypeptide or nucleic acid).
- Chrromatographic adsorbent refers to a material typically used in chromatography.
- Biospecific adsorbent refers an adsorbent comprising a biomolecule, e.g., a nucleic acid molecule (e.g., an aptamer), a polypeptide, a polysaccharide, a lipid, a steroid or a conjugate of these (e.g., a glycoprotein, a lipoprotein, a glycolipid, a nucleic acid (e.g., DNA)-protein conjugate).
- adsorbents for use in SELDI can be found in U.S. Patent 6,225,047 (Hutchens and Yip, "Use of retentate chromatography to generate difference maps," May 1, 2001).
- a SEAC probe is provided as a pre-activated surface that can be modified to provide an adsorbent of choice.
- certain probes are provided with a reactive moiety that is capable of binding a biological molecule through a covalent bond.
- Epoxide and carbodiimidizole are useful reactive moieties to covalently bind biospecific adsorbents such as antibodies or cellular receptors.
- affinity mass spectrometry involves applying a liquid sample comprising an analyte to the adsorbent surface of a SELDI probe.
- Analytes such as polypeptides, having affinity for the adsorbent bind to the probe surface.
- the surface is then washed to remove unbound molecules, and leaving retained molecules. The extent of analyte retention is a function of the stringency of the wash used.
- An energy absorbing material e.g., matrix
- Retained molecules are then detected by laser desorption/ionization mass spectrometry.
- SELDI is useful for protein profiling, in which proteins in a sample are detected using one or several different SELDI surfaces.
- protein profiling is useful for difference mapping, in which the protein profiles of different samples are compared to detect differences in protein expression between the samples.
- SEND Surface-Enhanced Neat Desorption
- SEND probe comprising a layer of energy absorbing molecules attached to the probe surface. Attachment can be, for example, by covalent or non-covalent chemical bonds.
- the analyte in SEND is not required to be trapped within a crystalline matrix of energy absorbing molecules for desorption/ionization.
- operative contact refers to a state in which the analyte and the EAM are sufficiently proximate each other that the excited EAM transfers energy to the analyte.
- SEAC/SEND is a version of SELDI in which both a capture reagent and an energy absorbing molecule are attached to the sample presenting surface. SEAC/SEND probes therefore allow the capture of analytes through affinity capture and desorption without the need to apply external matrix.
- the Cl 8 SEND chip is a version of SEAC/SEND, comprising a Cl 8 moiety which functions as a capture reagent, and a CHCA moiety that functions as an energy absorbing moiety.
- SEPAR Surface-Enhanced Photolabile Attachment and Release
- SELDI Surface-Enhanced Photolabile Attachment and Release
- Eluant or "wash solution” refers to an agent, typically a solution, which is used to affect or modify adsorption of an analyte to an adsorbent surface and/or remove unbound materials from the surface.
- the elution characteristics of an eluant can depend, for example, on pH, ionic strength, hydrophobicity, degree of chaotropism, detergent strength and temperature.
- Monitoring refers to recording changes in a continuously varying parameter.
- Data generation in mass spectrometry begins with the detection of ions by an ion detector.
- a typical laser desorption mass spectrometer can employ a nitrogen laser at 337.1 run.
- a useful pulse width is about 4 nanoseconds.
- power output of about 1-25 ⁇ J is used.
- Ions that strike the detector generate an electric potential that is digitized by a high speed time-array recording device that digitally captures the analog signal.
- Ciphergen's ProteinChip ® system employs an analog-to-digital converter (ADC) to accomplish this.
- the ADC integrates detector output at regularly spaced time intervals into time-dependent bins. The time intervals typically are one to four nanoseconds long.
- time-of- flight spectrum ultimately analyzed typically does not represent the signal from a single pulse of ionizing energy against a sample, but rather the sum of signals from a number of pulses. This reduces noise and increases dynamic range.
- This time-of-flight data is then subject to data processing.
- data processing typically includes TOF-to-M/Z transformation, baseline subtraction, high frequency noise filtering.
- TOF-to-M/Z transformation involves the application of an algorithm that transforms times-of-flight into mass-to-charge ratio (M/Z). In this step, the signals are converted from the time domain to the mass domain. That is, each time-of-flight is converted into mass-to-charge ratio, or M/Z.
- Calibration can be done internally or externally.
- the sample analyzed contains one or more analytes of known M/Z. Signal peaks at times-of-flight representing these massed analytes are assigned the known M/Z. Based on these assigned M/Z ratios, parameters are calculated for a mathematical function that converts times-of-flight to M/Z.
- a function that converts times-of-flight to M/Z such as one created by prior internal calibration, is applied to a time- of-flight spectrum without the use of internal calibrants.
- Baseline subtraction improves data quantification by eliminating artificial, reproducible instrument offsets that perturb the spectrum. It involves calculating a spectrum baseline using an algorithm that incorporates parameters such as peak width, and then subtracting the baseline from the mass spectrum.
- High frequency noise signals are eliminated by the application of a smoothing function.
- a typical smoothing function applies a moving average function to each time- dependent bin.
- the moving average filter is a variable width digital filter in which the bandwidth of the filter varies as a function of, e.g., peak bandwidth, generally becoming broader with increased time-of-flight. See, e.g., WO 00/70648, November 23, 2000 (Gavin et al., "Variable Width Digital Filter for Time-of-flight Mass Spectrometry").
- a computer can transform the resulting spectrum into various formats for displaying.
- spectrum view or retentate map a standard spectral view can be displayed, wherein the view depicts the quantity of analyte reaching the detector at each particular molecular weight.
- peak map a standard spectral view
- peak map only the peak height and mass information are retained from the spectrum view, yielding a cleaner image and enabling analytes with nearly identical molecular weights to be more easily seen.
- gel view each mass from the peak view can be converted into a grayscale image based on the height of each peak, resulting in an appearance similar to bands on electrophoretic gels.
- 3- D overlays In yet another format, referred to as "3- D overlays,” several spectra can be overlaid to study subtle changes in relative peak heights.
- difference map view two or more spectra can be compared, conveniently highlighting unique analytes and analytes that are up- or down- regulated between samples.
- Analysis generally involves the identification of peaks in the spectrum that represent signal from an analyte. Peak selection can, of course, be done by eye. However, software is available as part of Ciphergen's ProteinChip® software that can automate the detection of peaks. In general, this software functions by identifying signals having a signal- to-noise ratio above a selected threshold and labeling the mass of the peak at the centroid of the peak signal. In one useful application many spectra are compared to identify identical peaks present in some selected percentage of the mass spectra. One version of this software clusters all peaks appearing in the various spectra within a defined mass range, and assigns a mass (M/Z) to all the peaks that are near the mid-point of the mass (M/Z) cluster.
- M/Z mass
- the invention provides a host-guest complex that includes a molecular host complexed with an energy-absorbing molecule that absorbs photo-irradiation from an energy source to promote desorption/ionization of an analyte from a surface.
- energy absorbing molecules absorb photo-irradiation, such as laser energy, and generate thermal energy.
- the thermal energy is believed to be transferred to an analyte in operative contact with the energy-absorbing molecule.
- the transferred energy is believed to promote desorption from the surface and ionization of the analyte. hi this way, large biomolecules can be desorbed essentially intact from the surface of a probe.
- the complex is immobilized on a substrate that is a component of a probe for a mass spectrometer, e.g., a substrate that includes a means for engaging a probe interface of a mass spectrometer.
- Exemplary hosts include chelating agents, crown ethers, cryptands, calixarenes, spherands and a polymeric, cyclic structure, e.g., cyclodextrin.
- host-guest chemistry to prepare a matrix allows an unprecedented degree of flexibility to be engineered into a matrix, surface and device of the invention.
- host molecules to bind guest compounds (“inclusion") is well known to those of skill in the art. See, for example, Pitt et al.
- the host is a cyclodextrin or modified cyclodextrin (FIG. 1).
- Cyclodextrins are a group of cyclic oligosaccharides produced by numerous microorganisms. Cyclodextrins have a ring structure that has a basket-like shape. This shape allows cyclodextrins to include many kinds of molecules into their internal cavity. See, for example, Szejtli, J., CYCLODEXTRINS AND THEIR INCLUSION COMPLEXES; Akademiai Klado, Budapest, 1982; and Bender et al, CYCLODEXTRIN CHEMISTRY, Springer- Verlag, Berlin, 1978.
- Cyclodextrins are able to form inclusion complexes with an array of organic molecules including, for example, drugs, pesticides, herbicides and agents of war. See, Tenjarla et al., J. Pharm. Sci. 87:425-429 (1998); Switzerlandhul etal, Pharm. Dev. Technol. 3:43-53 (1998); and Albers et al, Crit. Rev. Ther. Drug Carrier Syst. 12:311-337 (1995). Cyclodextrins are also able to discriminate between enantiomers of compounds in their inclusion complexes. See, Koppenhoefer et al J. Chromatogr. A 793:153-164 (1998).
- cyclodextrin binding functionality can be attached to a spacer arm or directly to the substrate. See, Yamamoto et al, J. Phys. Chem. B 101:6855-6860 (1997). Methods to attach cyclodextrins to other molecules are well known to those of skill in the chromatographic and pharmaceutical arts. See, Sreenivasan, K. J. Appl. Polym. ScL 60:2245-2249 (1996). Because of their well- studied, diverse and robust complexation chemistry, cyclodextrins provide an EAM having properties that are unique and generally superior to a matrix prepared by applying a solution of the, generally hydrophobic, EAM to the sample.
- EAMs used in laser desorption/ionization mass spectrometry are essentially insoluble in water.
- the physiochemical properties of EAMs can be altered through their formation of inclusion complexes with cyclodextrins.
- a water-soluble host e.g., cyclodextrin
- the present invention also provides a water-soluble EAM that includes an EAM-host complex that is more soluble in water than the uncomplexed EAM.
- Exemplary EAM according to this embodiment of the invention are set forth herein.
- the EAM can be applied to an analyte in a manner that is generally similar to methods used with uncomplexed EAM.
- This embodiment of the invention includes a notable distinction from prior methods; the EAM is applied as an aqueous solution, rather than as a solute in an essentially organic solvent or organic/water co-solvent. Because the solvents for the analyte and the EAM are both aqueous they are essentially freely miscible. Thus, difficulties associated with the immiscibility of the EAM solvent with the analyte solvent, e.g., EAM aggregation, irregular crystal size, and the like, are minimized or avoided entirely.
- the invention also provides a mass spectrometric probe, e.g., a chip that is configured to allow it to be positioned within the sample chamber of a mass spectrometer.
- the chips include a host-guest (EAM) complex on their surface.
- the chips include the host on the surface, providing a device on which a EAM can be formed by the operator prior to use.
- the complexes, surfaces and devices of the invention can be used in the acquisition of data regarding an analyte in a laser assisted desorption/ionization mass spectrometric modality.
- chips that incorporate a EAM of the invention can be used to analyze a single peptide (FIG. 4 and FIG. 5), and mixtures of peptides (FIG. 6). Due to its readily controlled and reproduced structure, the EAM of the invention provides reproducible results in mass spectrometric analyses.
- Energy absorbing molecules include those molecules capable of absorbing photo- irraditation and promoting desorption/ionization of analyte molecules in operative contact therewith.
- the EAM can absorb ultraviolet light.
- the EAM can absorb infrared light.
- the EAM has the formula:
- Rl represents a bond, substituted or unsubstituted alkyl or substituted or unsubstituted heteroalkyl.
- R la is H, OH or substituted or unsubstituted alkyl.
- Exemplary aryl and heteroary moieties of use as Ar groups include:
- R 2 , R 3 , and R 4 independently represent H or substituted or unsubstituted alkyl, e.g., C 1 -C 6 unsubstituted alkyl.
- R 1 has the formula:
- R 5 and R 6 independently represent H, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, or CN.
- R and R groups include:
- Exemplary EAMs include ⁇ -cyano-4-hydroxycinnamic acid; sinapic acid, 2-(4- hydroxyphenylazo) benzoic acid; 2-Mercapto-benzothiazole; succinic acid; 2,6-hihydroxy acetophenone; ferulic acid; caffeic acid; 4-nitroaniline; 2,4,6-trihydroxy acetophenone; 3- hydroxy picolinic acid; anthranilic acid; nicotinic acid; salicylamide; trans- 3-indoleacrylic acid; dithranol; 2,5-Dihydroxy benzoic acid; succinic acid; 2,5-dihydroxy benzoic acid; isovanillin; 2,5-dihydroxybenzoic acid; 3-aminoquinoline; 2,4,6-; dithranol ; T-2-(3-(4-t- butyl-phenyl)- 2-methyl- 2-propenylidene) malononitrile; and 1-isoquinolinone
- the complex of this invention is comprised in a polymer in which the cyclodextrin is a component of the polymer.
- the polymer is selected from cyclodextrin homopolymers and cyclodextrin copolymers; either of which is optionally cross-linked by one or more cross-linking moieties.
- Selected cyclodextrin polymers are commercially available (e.g., CarboMer, Inc. Cat. # 4-00236).
- the cyclodextrin is covalently bonded to the polymer, either in the polymer backbone or as a substituent along the polymer chain.
- the art is replete with developed methods for preparing cyclodextrin polymers. Those of skill in the art will readily appreciate that essentially any cyclodextrin polymer capable of forming a complex with an EAM is of use in the device and methods of the invention.
- the present invention utilizes a cyclodextrin copolymer that is formed using epichlorhydrin. See, e.g., Nestle (NETH 6505361) and by Solms and EgIi (HeIv. Chim. Acta 48: 1225 (1965); U.S. Patent No. 3,420,788); GB 1,244,990; Wiedenhof et al., Die Starke 21(5): 119-123 (1969); Hoffman, J Macromol. Sci-Chem., A7(5): 1147- 1157 (1973); and Japanese patents JP-A-58171404 and JP 61283601.
- cyclodextrin polymers of use are prepared using a process using a dialdehyde, a dibasic acid, a diester, a dibasic acid dichloride, a diepoxide, a diisocyanate or a dihalogenated derivative is described in U.S. Pat. No. 3,472,835.
- cyclodextrin polymers prepared by a process using polyisocyanates in organic aprotic solvents (U.S. Patent No. 4,917,956; Asanuma et al., Chem. Commun., 1971 (1997) and in WO-A-98 22197).
- Additional useful cyclodextrin polymers are those that include ethylene glycol moieties within their structural framework.
- An exemplary process for preparing such polymers uses ethylene glycol bis(epoxypropyl) ether (Fenyvesi et al. (Ann. Univ. Sci. Budapest, Rolando Eotvos Nominatae, Sect. Chim. 15: 13-22 (1979)).
- a process using other diepoxy compounds has also been described by Sugiura et al.(Bull. Chem. Soc. Jpn., 62: 1643-1651 (1989)).
- a second type of polymer, where the cyclodextrin is a pendent group from a polymer chain is of use in the present invention.
- Exemplary polymers having this motif are produced by grafting cyclodextrin(s) or cyclodextrin derivative(s) to a pre-existing polymer chain.
- a reactive dextran intermediates e.g., a halotriazine and halopyrimidine derivative of cyclodextrins are used to attach the cyclodextrin moieties to the backbone. See, e.g., DE 19520989.
- Cyclodextrins can also be functionalized with aldehyde groups, and then grafted onto an amine-containing polymer, e.g., chitosan by a reductive amination reaction are of use. See, for example, Tomoya et al, J Polym. ScL, Part A: Polym. Chem., 36 (11): 1965-1968 (1998).
- cyclodextrin intermediates are also of use for the preparation of polymers and the substrate attachment of both cyclodextrin polymers and monomers.
- cyclodextrin that is runctionalized with a polymerizable functional group e.g., acryloyl or methacryloyl groups
- a polymerizable functional group e.g., acryloyl or methacryloyl groups
- a polymerizable functional group e.g., acryloyl or methacryloyl groups
- a methacryloyloylated cyclodextrin is homo- polymerized or copolymerized.
- co-polymerization proceeds with a crosslinking agent, such as poly(ethylene glycol)dimethacrylate, to form a cross-linked polymer.
- a crosslinking agent such as poly(ethylene glycol)dimethacrylate
- the polymerization can be initiated by the addition of a peroxide, such as lauroyl peroxide.
- the polymer is purified by methods known in the art, e.g., extraction of unreacted monomers, precipitation, crystallization, fractional crystallization, size exclusion chromatography, dialysis and the like.
- the polymer is also characterized by art-recognized methods, e.g., NMR, IR, size exclusion chromatography, elemental analysis and the like.
- the cyclodextrin is runctionalized with a binding moiety, as described further below.
- at least one of the hydroxyl moieties of the cyclodextrin is derivatized, providing a group of the formula:
- R 7 is a moiety that comprises a binding functionality.
- a percentage of the polymer is cross-linked.
- Any cross- linking agent, useful to crosslink the components of the polymer can be used to prepare the host-polymer of the invention.
- the cross-linking agent is a polyol or a polyisocyanate having.
- the crosslinking agent is a polymerizable monomer.
- Members of this class are those wherein at least one and preferably most of such linkages are conjugated with a double bonded carbon, including carbon double bonded to carbon and to such heteroatoms as nitrogen, oxygen and sulfur.
- such materials wherein the ethylenically unsaturated groups, especially the vinylidene groups, are conjugated with ester or amide structures and the like.
- this group may be used to bind the complex or polymers to the surface of a substrate, e.g., through an anchor moiety via reaction of complementary reactive functional groups on the cyclodextrin-containing species and an anchor reagent.
- a reactive functional group on the anchor reagent is used to tether the cyclodextrin- containing species to the substrate.
- An exemplary anchor moiety of use in immobilizing the polymers of the invention on a substrate is shown in FIG. 7, and its attachment to a glass surface is shown in FIG. 8.
- FIG. 7 An exemplary anchor moiety of use in immobilizing the polymers of the invention on a substrate is shown in FIG. 7, and its attachment to a glass surface is shown in FIG. 8.
- FIG. 7 An exemplary anchor moiety of use in immobilizing the polymers of the invention on a substrate is shown in FIG. 7, and its attachment to a glass surface is shown in FIG. 8.
- FIG. 8 For example, by providing free vinyl groups or benzophenone groups in the polymer
- An exemplary cross-linked polymer of the invention is a hydrogel. 2.5. Functionalized Complexes and Polymers
- the host-guest complex or the host-guest complex polymer further comprise a functional group for binding a target.
- the functional groups are reactive functional groups that covalently bind the target.
- the functional groups are binding functional groups that bind a target non- covalently. Exemplary functional groups and functionalization chemistries of use in the present invention are set forth in FIG. 9. 2.5.1.1. Reactive Functional Groups
- Exemplary reactive functional groups include:
- hydroxyl groups which can be converted to esters, ethers, aldehydes, etc.
- haloalkyl groups wherein the halide can be later displaced with a nucleophilic group such as, for example, an amine, a carboxylate anion, thiol anion, carbanion, or an alkoxide ion, thereby resulting in the covalent attachment of a new group at the site of the halogen atom
- dienophile groups which are capable of participating in Diels-Alder reactions such as, for example, maleimido groups
- aldehyde or ketone groups such that subsequent derivatization is possible via formation of carbonyl derivatives such as, for example, imines, hydrazones, semicarbazones or oximes, or via such mechanisms as Grignard addition or alky llithium addition;
- thiol groups which can be converted to disulfides or reacted with acyl halides
- amine or sulfhydryl groups which can be, for example, acylated or alkylated
- alkenes which can undergo, for example, cycloadditions, acylation, Michael addition, etc.
- the reactive functional groups can be chosen such that they do not participate in, or interfere with reactions in which they are not intended to participate. Alternatively, the reactive functional group can be protected from participating in the reaction by the presence of a protecting group. Those of skill in the art will understand how to protect a particular functional group from interfering with a chosen set of reaction conditions. For examples of useful protecting groups, See, Greene et ah, PROTECTIVE GROUPS IN ORGANIC SYNTHESIS, John Wiley & Sons, New York, 1991.
- An exemplary complex or polymer of the invention can include a binding functionality. Binding functionalities (which also can be attached through reactive functionalities) are useful for capturing analytes from a sample for further analysis. Binding functionalities may be grouped into two classes - chromatographic binding groups and biospecific binding groups. [0112] Chromatographic binding functionalities include those typically used in chromatography, and they tend to bind substances via charge-charge, hydrophilic- hydrophilic, hydrophobic-hydrophobic, van der Waals interactions and combinations thereof. They include, for example, ion exchange functionalities (anion and cation), hydrophobic functionalities, hydrophilic functionalities, metal chelate functionalities and dye functionalities.
- the binding functionality is selected from the group consisting of a positively charged moiety, a negatively charged moiety, an anion exchange moiety, a cation exchange moiety, a metal ion complexing moiety, a metal complex, a polar moiety and a hydrophobic moiety.
- Ion exchange moieties of use as binding functionalities in the polymers of the invention are, e.g., diethylaminoethyl, triethylamine, sulfonate, tetraalkylammonium salts and carboxylate.
- the binding functionality is a polyaminocarboxylate chelating agent such as ethylenediaminetetraacetic acid (EDTA) or diethylenetriaminepentaacetic acid (DTPA), which is attached to an amine on the substrate, or spacer arm, by utilizing the commercially available dianhydride (Aldrich Chemical Co., Milwaukee, WI).
- EDTA ethylenediaminetetraacetic acid
- DTPA diethylenetriaminepentaacetic acid
- the metal chelate binds to tagged species, such as polyhistidyl-tagged proteins, which can be used to recognize and bind target species.
- the metal ion itself, or a species complexing the metal ion can be the target.
- Metal ion complexing moieties include, but are not limited to N- hydroxyethylethylenediaminoe-triacetic acid (NTA), N,N-bis(carboxymethyl)-L-lysine, iminodiacetic acid, aminohydroxamic acid, salicylaldehyde, 8-hydroxy-quinoline, N 5 N 5 N'- tris(carboxytrimethyl)ethanolamine, and N-(2-pyridylmethyl) aminoacetate.
- the metal ion complexing agents can complex any useful metal ion, e.g., copper, iron, nickel, cobalt, gallium and zinc.
- the binding functionality is a biomolecule, e.g., a natural or synthetic peptide, antibody (including binding fragments thereof, such as Fab' or F(ab') 2 ), nucleic acid, saccharide, lectin, member of a receptor/ligand binding pair, antigen, cell or a combination thereof.
- the binding functionality is an antibody raised against a target or against a species that is structurally analogous to a target.
- the binding functionality is avidin, or a derivative thereof, which binds to a biotinylated analogue of the target
- the binding functionality is a nucleic acid, which binds to single- or double-stranded nucleic acid target having a sequence complementary to that of the binding functionality.
- the binding functionality is selected from nucleic acid species, such as aptamers and aptazymes that recognize specific targets.
- the binding functionality is a drug moiety or a pharmacophore derived from a drug moiety.
- the drug moieties can be agents already accepted for clinical use or they can be drugs whose use is experimental, or whose activity or mechanism of action is under investigation.
- the drug moieties can have a proven action in a given disease state or can be only hypothesized to show desirable action in a given disease state.
- the drug moieties are compounds, which are being screened for their ability to interact with a target of choice.
- drug moieties, which are useful in practicing the instant invention include drags from a broad range of drag classes having a variety of pharmacological activities.
- This invention contemplates devices in which the surface of a substrate is coated with the monomeric or polymeric complexes of this invention.
- the complexes can be bound to the surface by any means, including covalent or non-covalent chemical bonding, or simply physical attachment by applying the complex to the substrate surface where it sticks.
- the devices of this invention can come in the form of chips, resins (e.g., beads), microtiter plates or membranes.
- the complex is immobilized on a substrate, either directly or through linker arms that are interposed between the substrate and the adsorbent film.
- a substrate e.g., a chip of the invention is typically based upon a planar substrate format.
- a chromatographic support of the invention generally makes use of a spherical or approximately spherical substrate, while a membrane of the invention is formed using a porous substrate.
- a microtiter plate is generally a plastic article of manufacture comprising wells in which reactions can be performed.
- Exemplary chips of the invention are formed using a planar substrate.
- the complex is applied directly to the substrate or is bound to an anchor moiety that is bound to the substrate surface, or to a feature on the substrate surface, such as a region that is raised (e.g., island) or depressed (e.g., a well, trough, etc.).
- the complex in either polymer or monomer form, is generally immobilized on the chip substrate.
- the interaction between the polymer and the substrate can be a covalent, electrostatic, ionic, hydrogen bonding, hydrophobic-hydrophobic, hydrophilic-hydrophilic interaction or physisorption or physical adhesion.
- Substrates that are useful in practicing the present invention can be made of any stable material, or combination of materials.
- useful substrates can be configured to have any convenient geometry or combination of structural features.
- the substrates can be either rigid or flexible and can be either optically transparent or optically opaque.
- the substrates can also be electrical insulators, conductors or semiconductors. When the sample to be applied to the chip is water based, the substrate preferable is water insoluble.
- the substrate material is essentially non-reactive with the analyte, thus preventing non-specific binding between the substrate and the analyte or other components of an assay mixture.
- Methods of coating substrates with materials to prevent non-specific binding are generally known in the art.
- Exemplary coating agents include, but are not limited to cellulose, bovine serum albumin, and poly(ethylene glycol). The proper coating agent for a particular application will be apparent to one of skill in the art.
- the substrate includes an aluminum support that is coated with a layer of silicon dioxide.
- the silicon dioxide layer is from about 1000-3000 A in thickness.
- the substrate comprises a polymeric material, such as cellulose or a plastic.
- the EAM-host complex is not anchored to a surface and it is essentially water-soluble, or at least more water-soluble than the EAM alone.
- the invention provides the first essentially water-soluble EAM for use in laser desorption/ionization mass spectrometry.
- an aqueous solution of the water- soluble EAM can be used in a manner analogous to that presently used with EAM solutions in organic solvent.
- the complex either in monomeric or polymeric forms, can be mixed with the analyte before application to the probe surface. Alternatively, either the complex or the analyte can be applied to the probe surface and the other can be applied subsequently.
- the host-guest EAM complex When the host-guest EAM complex is covalently bound to the surface, it can be tethered to the surface by means of an anchor moiety that is formed by reacting a group on an anchor reagent with a group of complementary reactivity on a substrate surface; and reacting a group on the free or surface-tethered anchor reagent with a group of complementary reactivity on the host; these reactions are performed in any useful sequence.
- An exemplary anchor moiety is set forth in FIG. 7.
- FIG. 8 provides a putative structure of the anchor moiety bound to a glass surface. Both monomeric and polymeric complexes can be tethered to the surface.
- the anchor moiety will generally include a first functional group of reactivity complementary to the bonds at the surface of the glass, and a second reactive functionality that forms a covalent bond with a reactive functionality of complementary reactivity on the host.
- the complex includes a host that is a cylcodextrin moiety.
- reagents include, but are not limited to:
- hydroxyalkyl siloxanes (Silylate surface, functionalize with diborane, and H 2 O 2 to oxidize the alcohol) a. allyl trichlorosilane — > — > 3-hydroxypropyl, b. 7-oct-l-enyl trichlorchlorosilane -» -» 8-hydroxyoctyl; 2. diol (dihydroxyalkyl) siloxanes (silylate surface and hydrolyze to diol) a. (glycidyl trimethoxysilane -> -> (2,3-dihydroxypropyloxy)propyl;
- aminoalkyl siloxanes (amines requiring no intermediate functionalizing step) a. 3-aminopropyl trimethoxysilane -» aminopropyl;
- dimeric secondary aminoalkyl siloxanes a. bis (3-trimethoxysilylpropyl) amine -> bis(silyloxylpropyl)amine;
- Exemplary anchor reagents according to motif 4, above include styrylethyltrimethoxysilane, styrylethylmethyldimethoxysilane, styrylethyldimethylmethoxysilane, styrylethyltrichlorosilane, styrylethylmethyldimethoxysilane, styrylethyldimethylmethoxysilane, (3- acryloxypropyl)trimethoxysilane, (3 -acryloxypropyl)methyldimethoxysilane, (3 - acryloxypropyl)dimethylmethoxysilane, (3 -acryloxypropyl)trichlorosilane, (3 -acryloxypropyl)methyldichlorosilane, (3 -acryloxy
- the surface of a substrate of use in practicing the present invention can be smooth, rough and/or patterned.
- the surface can be engineered by the use of mechanical and/or chemical techniques.
- the surface can be roughened or patterned by rubbing, etching, grooving, stretching, and the oblique deposition of metal films.
- the substrate can be patterned using techniques such as photolithography (Kleinf ⁇ eld et ah, J. Neurosci. 8: 4098-120 (1998)), photoetching, chemical etching and microcontact printing (Kumar et ah, Langmuir 10: 1498-511 (1994)). Other techniques for forming patterns on a substrate will be readily apparent to those of skill in the art.
- the size and complexity of the pattern on the substrate is controlled by the resolution of the technique utilized and the purpose for which the pattern is intended. For example, using microcontact printing, features as small as 200 run have been layered onto a substrate. See, Xia, Y.; Whitesides, G., J Am. Chem. Soc. 117: 3274-75 (1995). Similarly, using photolithography, patterns with features as small as 1 ⁇ m have been produced. See, Hickman et al, J. Vac. ScL Technol. 12: 607-16 (1994). Patterns that are useful in the present invention include those which comprise features such as wells, enclosures, partitions, recesses, inlets, outlets, channels, troughs, diffraction gratings and the like.
- the patterning is used to produce a substrate having a plurality of adjacent addressable features, wherein each of the features is separately identifiable by a detection means.
- an addressable feature does not fluidically communicate with other adjacent features.
- an analyte, or other substance, placed in a particular feature remains essentially confined to that feature.
- the patterning allows the creation of channels through the device whereby fluids can enter and/or exit the device.
- substrates with patterns having regions of different chemical characteristics can be produced.
- an array of adjacent, isolated features is created by varying the hydrophobicity/hydrophilicity, charge or other chemical characteristic of a pattern constituent.
- hydrophilic compounds can be confined to individual hydrophilic features by patterning "walls" between the adjacent features using hydrophobic materials.
- positively or negatively charged compounds can be confined to features having "walls” made of compounds with charges similar to those of the confined compounds.
- Similar substrate configurations are also accessible through microprinting a layer with the desired characteristics directly onto the substrate. See, Mrkish, M.; Whitesides, G.M., Ann. Rev. Biophys. Biomol. Struct. 25:55-78 (1996).
- the specificity and multiplexing capacity of the chips of the invention is improved by incorporating spatial encoding ⁇ e.g., spotted microarrays) into the chip substrate.
- Spatial encoding can be introduced into each of the chips of the invention.
- binding functionalities for different analytes can be arrayed across the chip surface, allowing specific data codes (e.g. , target-binding functionality specificity) to be reused in each location.
- the array location is an additional encoding parameter, allowing the detection of a virtually unlimited number of different analytes.
- m binding functionalities distributed over m regions of the substrate.
- Each of the m binding functionalities can be a different functionality or the same functionality, or different functionalities can be arranged in patterns on the surface. For example, in the case of matrix array of addressable locations, all the locations in a single row or column can have the same binding functionality.
- the m binding functionalities are preferably patterned on the substrate in a manner that allows the identity of each of the m locations to be ascertained.
- the m binding functionalities are ordered in a p by q matrix of (p x q) discrete locations, wherein each of the (p x q) locations has bound thereto at least one of the m binding functionalities.
- the microarray can be patterned from essentially any type of binding functionality.
- the chip of this invention is designed in the form of a probe for a gas phase ion spectrometer, such as a mass spectrometry probe.
- the substrate of the chip is generally configured to comprise .means that engage a complementary structure within the interface.
- the term "positioned" is generally understood to mean that the chip can be moved into a position within the sample chamber in which it resides in appropriate alignment with the energy source for the duration of a particular desorption/ionization cycle.
- An exemplary structure according to this description is a chip that includes means for slidably engaging a groove in an interface, such as that used in the Ciphergen probes (FIG. 10).
- the means to position the probe in the sample chamber is integral to substrate 101, which includes a lip 102 that engages a complementary receiving structure in the probe.
- the probe is round and is typically attached to a holder / actuator using a magnetic coupler. The target is then pushed into a repeller and makes intimate contact to insure positional and electrical certainty.
- probes are rectangular and they either marry directly to a carrier using a magnetic coupling or physically attach to a secondary carrier using pins or latches.
- the secondary carrier then magnetically couples to a sample actuator. This approach is generally used by systems which have autoloader capability and the actuator is generally a classical x,y 2-d stage.
- the probe is a barrel.
- the barrel was used to support gel pieces o r blots. By rotating and moving in the vertical plane, a 2-d stage is created.
- the probe is a disk.
- the disk is rotated and moved in either a vertical or horizontal position to create an r-theta stage.
- Such disks are typically engaged using either magnetic or compression couplers.
- the solid substrate is an organic material.
- the organic material is cellulose, agarose, dextran, polyacrylates, polystyrene, polyacrylamide, polymethacrylamide, copolymers of styrene and divinylbenzene, or mixtures thereof.
- the solid support is an inorganic material, preferably one selected from hydrogel-containing silica, zirconia, alumina, titania, ceramics, and mixtures thereof.
- the invention provides methods of making complexes and devices of the invention.
- An advantage of the method set forth herein for forming a matrix is the ease of preparation of industrially relevant amounts of a compound that includes a host moiety as a component of its structure, referred to herein as a "host- containing species," or an EAM complex of this species. Access to batches of the components necessary to form the complexes, surfaces and chips of the invention allows the formation of a multitude of chips having essentially identical properties.
- the methods of the invention provide a matrix with EAM loadings that are freely tunable.
- Complexes of the invention are prepared by bringing a host and guest into contact under conditions that promote the formation of the complex.
- General conditions for forming such complexes are art-recognized; developing appropriate conditions for a selected application is well within the abilities of those of skill in the art.
- An exemplary host-guest complex is a cyclodextrin, or a cyclodextrin homopolymer or co-polymer complexed with an EAM such as those described above.
- the present application includes examples of forming the complexes.
- the invention provides a method for making a plurality of adsorbent devices that include a host or a host-guest EAM complex.
- Each member of the plurality of devices includes: (a) a solid support having a surface; and (b) an adsorbent film that includes a host or a host-guest complex on the surface.
- each solid support is contacted with an aliquot of a single preparation, i.e., batch, of a compound that includes a host moiety as a component of its structure, referred to herein as a "host-containing species.” The aliquot is sampled from a single batch of the host-containing species or an EAM complex of the host-containing species.
- a preferred size for a single batch of the host-containing species is from about 0.5 liters and 5 liters.
- the single batch is preferably of sufficient volume to prepare a total area of addressable locations of least about 500,000 mm 2 , preferably from about 500,000 mm 2 to about 50,000,000 mm 2 , more preferably from about 100,000 to about 5,000,000 addressable locations.
- the surface, once laid down on the substrate, is amenable to functionalization by a variety of chemical reactions known to those skilled in the art.
- a reactive host-containing species is reacted with a suitable amine (e.g. dimethylethanol amine or trimethyl amine), producing a quaternary ion exchange site.
- a suitable amine e.g. dimethylethanol amine or trimethyl amine
- the host-guest EAM complexes of this invention are useful for detecting analytes, in particular in connection with mass spectrometry, but also with other methods of surface detection.
- the analyte in, e.g., an aqueous solution, is mixed with a complex of the invention in either monomeric or polymeric form. The mixture is applied to the surface of a probe, engaged with an interface of a mass spectrometer, and then detected by laser desorption/ionization mass spectrometry.
- a chip coated with a monomeric or polymeric complex of the invention is provided. A sample comprising an analyte is applied to the chip surface. Then the analyte is detected by mass spectrometry.
- the chip also comprises binding moieties that can bind the analyte non-covalently. After capture of the analyte, non-binding molecules are washed away. Then the analyte can be detected by mass spectrometry. In other embodiments, the analyte can be detected by other surface detection methods as well. Generally, these are suited to examine biospecific interactions between, for example, receptor and ligand. [0151] Upon capture on a chip, analytes can be detected by a variety of detection methods selected from, for example, a gas phase ion spectrometry method, an optical method, an electrochemical method, atomic force microscopy and a radio frequency method.
- Gas phase ion spectrometry methods are described herein. Of particular interest is the use of mass spectrometry and, in particular, SELDI.
- Optical methods include, for example, detection of fluorescence, luminescence, chemiluminescence, absorbance, reflectance, transmittance, birefringence or refractive index (e.g., surface plasmon resonance, ellipsometry, a resonant mirror method, a grating coupler waveguide method (e.g., wavelength-interrogated optical sensor) or interferometry).
- Optical methods include microscopy (both confocal and non- confocal), imaging methods and non-imaging methods.
- Immunoassays in various formats are popular methods for detection of analytes captured on a solid phase.
- Electrochemical methods include voltametry and amperometry methods.
- Radio frequency methods include multipolar resonance spectroscopy.
- Example 1 Complex Formation of ⁇ -Cyano-4-Hydroxylcinnamic Acid/ ⁇ - Cyclodextrin
- Control experiment to a solution of 30 g of DI H 2 OZDMF mixture (w/w, 7.5:1) was added 0.21 g of CHCA. The suspension was shaken for 12 h at 60 °C. The CHCA in the suspension remained undissolved.
- Control experiment to a solution of 30 g of DI H 2 (VDMF mixture (w/w, 7.5:1) was added 0.257 g of SPA. The suspension was shaken for 12 h at 60 °C. The SPA in the suspension remained undissolved.
- Control experiment to a solution of 25 g of DI H 2 CVDMF mixture (w/w, 85:15) was added 0.21 g of CHCA. The suspension was shaken for 12 h at 60 0 C. The CHCA in the suspension remained undissolved.
- SPA/ ⁇ -cyclodextrin complexes were used as an EAM in a SELDI analysis to assist the desorption and ionization of cytochrome C under typical laser condition.
- SELDI and ProteinChip For instructions of using SELDI and ProteinChip, see, for example, WO 00/66265 (Rich et al, "Probes for a Gas Phase Ion Spectrometer," November 9, 2000).
- the EAM complex of the invention was applied to an analyte in the same way as a non-complexed matrix.
- FIG. 4 and FIG. 5 show the mass spectrum of cytochrome C using a SPA/ ⁇ - cyclodextrin EAM complex to assist the desorption and ionization under typical analytical parameters.
- the results indicate that the SPA/ ⁇ -cyclodextrin EAM complex acts as a EAM to promote the desorption and ionization of cytochrome C.
- the sample was treated with ethanol to extract SPA out of the cavity before the desorption and ionization experiment.
- a SPA/ ⁇ -cyclodextrin polymer complex prepared according to Example 4 was used as an EAM to promote the desorption and ionization of ALL-in-1 protein standard under typical laser condition.
- SELDI and ProteinChip see, for example, WO 00/66265 (Rich et al., "Probes for a Gas Phase Ion Spectrometer," November 9, 2000).
- ALL-in-1 protein standard is a product available from Ciphergen Biosystems, Inc.
- All-in- 1 protein The components of the All-in- 1 protein are hirudin BHVK (MW 7,034 Dalton), cytochrome C (MW 12,230 Dalton), myoglobin (MW 16,951 Dalton), carbonic anhydrase (MW 29,023 Dalton), enolase (MW 46,671 Dalton), albumin (MW 66,433 Dalton), IgG (MW 147,300 Dalton).
- hirudin BHVK MW 7,034 Dalton
- cytochrome C MW 12,230 Dalton
- myoglobin MW 16,951 Dalton
- carbonic anhydrase MW 29,023 Dalton
- enolase MW 46,671 Dalton
- albumin MW 66,433 Dalton
- IgG IgG
- ALL-in-1 protein was dissolved in 25 ⁇ L of 20 mM ammonium acetate; (3) To a NP 20 ProteinChip, each spot was added with 1 ⁇ L of ALL-in-1 protein solution followed with 1 ⁇ L of DI H 2 O;
- FIG. 6 shows the mass spectrum of ALL-in-1 protein profile in the mass range 5,000-70,000 Daltons using an SPA/ ⁇ -cyclodextrin polymer EAM complex to promote the desorption and ionization process under typical laser conditions.
- the spectrum included the expected protein peaks.
- the results indicate that SPA/ ⁇ -cyclodextrin polymer acts as a EAM to promote the desorption and ionization of the components of ALL-in-1 protein.
- the sample was treated with ethanol to extract SPA out of the cavity before the desorption and ionization experiment.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61450904P | 2004-09-29 | 2004-09-29 | |
PCT/US2005/031972 WO2006039077A2 (en) | 2004-09-29 | 2005-09-08 | Host-guest enery-absorbing complex |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1802961A2 true EP1802961A2 (en) | 2007-07-04 |
EP1802961A4 EP1802961A4 (en) | 2007-11-14 |
Family
ID=36142954
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP05798023A Withdrawn EP1802961A4 (en) | 2004-09-29 | 2005-09-08 | Host-guest enery-absorbing complex |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1802961A4 (en) |
JP (1) | JP2008514956A (en) |
CA (1) | CA2582338A1 (en) |
WO (1) | WO2006039077A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060261267A1 (en) * | 2005-05-20 | 2006-11-23 | Agency For Science, Technology And Research | Composite MALDI matrix material and methods of using it and kits thereof in MALDI |
JP5980517B2 (en) * | 2012-02-13 | 2016-08-31 | 株式会社島津製作所 | Additives for matrix for mass spectrometry |
JP5885567B2 (en) * | 2012-04-05 | 2016-03-15 | 株式会社島津製作所 | Additives for matrix for mass spectrometry |
US10564076B2 (en) * | 2015-06-16 | 2020-02-18 | Agilent Technologies, Inc. | Compositions and methods for analytical sample preparation |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995015001A2 (en) * | 1993-11-12 | 1995-06-01 | Waters Corporation | Enhanced resolution maldi tof-ms sample surface |
US20030207460A1 (en) * | 2002-01-25 | 2003-11-06 | Ciphergen Biosystems, Inc. | Monomers and polymers having energy absorbing moieties of use in desorption/ionization of analytes |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994028418A1 (en) * | 1993-05-28 | 1994-12-08 | Baylor College Of Medicine | Method and apparatus for desorption and ionization of analytes |
-
2005
- 2005-09-08 JP JP2007534618A patent/JP2008514956A/en active Pending
- 2005-09-08 EP EP05798023A patent/EP1802961A4/en not_active Withdrawn
- 2005-09-08 WO PCT/US2005/031972 patent/WO2006039077A2/en active Application Filing
- 2005-09-08 CA CA002582338A patent/CA2582338A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995015001A2 (en) * | 1993-11-12 | 1995-06-01 | Waters Corporation | Enhanced resolution maldi tof-ms sample surface |
US20030207460A1 (en) * | 2002-01-25 | 2003-11-06 | Ciphergen Biosystems, Inc. | Monomers and polymers having energy absorbing moieties of use in desorption/ionization of analytes |
Non-Patent Citations (10)
Also Published As
Publication number | Publication date |
---|---|
EP1802961A4 (en) | 2007-11-14 |
WO2006039077A2 (en) | 2006-04-13 |
CA2582338A1 (en) | 2006-04-13 |
JP2008514956A (en) | 2008-05-08 |
WO2006039077A3 (en) | 2007-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20050112650A1 (en) | Reactive polyurethane-based polymers | |
US20060183863A1 (en) | Zwitterionic polymers | |
US7276381B2 (en) | Monomers and polymers having energy absorbing moieties of use in desorption/ionization of analytes | |
Zhou et al. | Specific phosphopeptide enrichment with immobilized titanium ion affinity chromatography adsorbent for phosphoproteome analysis | |
JP4587954B2 (en) | Protein interaction difference mapping | |
US20070082019A1 (en) | Photocrosslinked hydrogel surface coatings | |
US7842498B2 (en) | Hydrophobic surface chip | |
ES2444722T3 (en) | Mass Spectrum Analysis | |
US20070254378A1 (en) | Chelating monomers and polymers | |
JP2008500554A (en) | Sample presentation device | |
KR20020026427A (en) | Probes for a gas phase ion spectrometer | |
Niikura et al. | Versatile glycoblotting nanoparticles for high‐throughput protein glycomics | |
EP1731540A1 (en) | Polymer particle | |
US20030207462A1 (en) | Monomers and polymers having energy absorbing moieties of use in desorption/ionization of analytes | |
WO2006039077A2 (en) | Host-guest enery-absorbing complex | |
US7999221B2 (en) | Mass spectrometric detection of material transferred to a surface | |
US20050013733A1 (en) | Trace incorporation of fluorescent monomer facilitating quality control of polymerization reactions | |
CN101014852B (en) | Sample presentation device | |
US7183544B2 (en) | Bi-functional polymer chip | |
US20060183242A1 (en) | Phthalate polymers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20070427 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA HR MK YU |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: BIO-RAD LABORATORIES, INC. |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20071016 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: G01N 33/68 20060101AFI20071006BHEP |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: ROTH, STEVE Inventor name: HUANG, WENXI |
|
DAX | Request for extension of the european patent (deleted) | ||
17Q | First examination report despatched |
Effective date: 20080220 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20080702 |